Wyden Presses FDA and DEA on ADHD Drug Shortage
June 06, 2023
June 06, 2023
WASHINGTON, June 6 -- Sen. Ron Wyden, D-Oregon, issued the following news release on June 5, 2023 and a letter:
U.S. Senator Ron Wyden, D-Ore., today announced he is urging regulators at two federal agencies to provide a comprehensive explanation for the continued shortage of affordable, generic ADHD medications and how the agencies are working together to tackle this national crisis.
Wyden's letters to Drug Enforcement Agency (DEA) Administrator Anne Milgram and Food a . . .
U.S. Senator Ron Wyden, D-Ore., today announced he is urging regulators at two federal agencies to provide a comprehensive explanation for the continued shortage of affordable, generic ADHD medications and how the agencies are working together to tackle this national crisis.
Wyden's letters to Drug Enforcement Agency (DEA) Administrator Anne Milgram and Food a . . .